Clinical trial
Precise Treatment of Ceftazidime-Avibactam in Patients With CRO Infections Under the Guidance of TDM and PPK Model
NCT06210542 is registered in ClinicalTrials.gov with Sichuan Provincial People's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Precise Treatment of Ceftazidime-Avibactam in Patients With CRO Infections Under the Guidance of TDM and PPK Model
- Lead sponsor
- Sichuan Provincial People's Hospital
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- January 31, 2024
- Completion date
- December 31, 2026
- Enrollment
- 50 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
carbapenem-resistant enterobacteriaceae infection, ecmo